![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Nemaura’s Non-Invasive Continuous Glucose Monitor Gains CE Mark
Nemaura’s Non-Invasive Continuous Glucose Monitor Gains CE Mark
![](https://www.fdanews.com/ext/resources/test/Device_Images6/NemauraMedical_Logo.gif?t=1559169236&width=430)
Nemaura Medical has earned the CE Mark for its needle-free, skin-patch SugarBEAT continuous glucose monitor.
The device is a non-invasive, disposable patch that connects to a rechargeable transmitter. It is expected to help individuals with diabetes and pre-diabetics better track how lifestyle factors can impact daily glucose level trends, known as an Ambulatory Glucose Profile.
The monitor typically provides readings at five-minute intervals, or 12 per hour, which form an glucose profile that can be used to identify trends.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct